Talk:Ketorolac

From Wikipedia, the free encyclopedia

Ketorolac is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
B This article has been rated as B-Class on the quality scale.
Mid This article has been rated as Mid-importance for this Project's importance scale.

ketrolac reacts with sodium azide in presence of sulphuric acid and sodiumhydroxide , what is the formation of the product?

[edit] US specific information

Actually, "Dosage, availability and price" part is valid for US only, and US is not a typical example when we are talking about drugs. In Russia, for example, price is about 10 times less, and I think it's available over-the-counter in most of the world.

Good point, but it's still a good entry otherwise. I just got an injection of Toradol and wondered what it was. It answered all my questions. Eperotao 14:59, 13 July 2007 (UTC)

[edit] Proposal to merge Acular into Ketorolac

I'm interested: what are the reasons in favour of a merger? User:Jeff Dahl, it looks like you are proposing this. Could you tell us why it's a good idea? Personally, I don't feel strongly either way. However, I do note that the Ketorolac article now specifically excludes ophthalmic solutions of ketorolac, and that would have to change. --Jdlh | Talk 07:16, 4 September 2007 (UTC)

My reasoning on the proposed merger, besides the obvious point that it is the same active drug, is that the acular article doesn't really add much information except manufacturers and citations. The sources listed, links etc. are great, but the body of the article is little more than a few sentences that could be better integrated into the ketorolac article. Even if the acular article were expanded by putting in the drug information, it would be just a duplication of the ketorolac article. By merging, we can make the coverage of the ketorolac article more thorough. I am eager to hear what everyone thinks about it. Jeff Dahl 15:41, 4 September 2007 (UTC)
I have no objection to a merger, though don't feel strongly in favour either. The Wikipedia:Be bold principle gives you license to go ahead if no objection appears. If you want more input than this trickle, you could ask Wikipedia:WikiProject Pharmacology, or look at how other editors have handled this same topic for other cases. --Jdlh | Talk 18:58, 5 September 2007 (UTC)

It has now been a few days, no objections to merger, so I have performed it.Jeff Dahl 21:16, 11 September 2007 (UTC)

Thank you for being bold. --Jdlh | Talk 17:17, 13 September 2007 (UTC)

[edit] IUPAC Name

Perhaps something like this
Perhaps something like this

There are two IUPAC names given in the article:

  1. (±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid (C15H13NO3)
  2. 2-amino-2-(hydroxymethyl)-1,3-propanediol (C4H11NO3)

The pictured compound is the first of those two. The drug is named "ketorolac tromethamine" and is actually a salt in 1:1 ratio of the two components. I think should supply a picture containing both structures. ralmin 00:41, 16 October 2007 (UTC)